Vasopressin Analogue DDAVP in Diabetes Insipidus: Clinical and Laboratory Studies

No abstract is available for this paper.

• Publication year

  1973

• Venue

  British medical journal

• Publication date

  1973-08-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.3.5876.375PMID 4581079PMCID PMC1586660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanism of inactivation of vasopressin and oxytocin by the isolated perfused rat kidney.

  1973cited by this paper
• Radioimmunoassay for plasma antidiuretic hormone.

  1972cited by this paper
• The development of a radioimmunoassay for arginine-vasopressin: production of antisera and labelled hormone; separation techniques; specificity and sensitivity of the assay in aqueous solution.

  1972cited by this paper
• Demonstration of circulating antibodies to neurophysin in patients treated with pitressin.

  1971cited by this paper
• The development of a radioimmunoassay and a plasma extraction method for vasopressin.

  1970cited by this paper
• Potentiation of the antidiuretic effect of vasopressin by chlorpropamide.

  1970cited by this paper
• [Preliminary study of antidiuretic effect of clofibrate (or atromid S) in pitressosensitive diabetes insipidus].

  1970cited by this paper
• Potentiation of vasopressin action by chlorpropamide in vivo.

  1970cited by this paper
• Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus.

  1968cited by this paper
• STATISTICAL METHODS

  1967cited by this paper
• Hypersensitivity to pituitary snuff with miliary shadowing in the lungs.

  1967cited by this paper
• Antidiuretic action of chlorpropamide in idiopathic diabetes insipidus.

  1966cited by this paper
• [Endocrine diseases].

  1966cited by this paper
• [Does Tegretal offer new possibilities of therapy in several neurologic and endocrine diseases? A clinical electroencephalographic and thin-layer chromatographic study].

  1966cited by this paper
• Effect of Human Pregnancy Serum on Avian Depressor Activities of Oxytocin and Desamino-Oxytocin.∗

  1963cited by this paper
• Chlorothiazid in Diabetes Insipidus

  1959cited by this paper
• Collection of Czechoslovak Chemical Communications

  1947cited by this paper

• Desmopressin to prevent and treat bleeding in pregnant women with an inherited bleeding disorder: A systematic literature review.

  2023cites this paper
• Desmopressin Stimulates Nitric Oxide Production in Human Lung Microvascular Endothelial Cells

  2022cites this paper
• Desmopressin acetate the first sublingual tablet to treat nocturia due to nocturnal polyuria

  2021influential citation
• Degradation of Mutant Protein Aggregates within the Endoplasmic Reticulum of Vasopressin Neurons

  2020cites this paper
• Pediatric Pharmacology of Desmopressin in Children with Enuresis: A Comprehensive Review

  2020cites this paper
• Vasopressin Bolus Protocol Compared to Desmopressin (DDAVP) for Managing Acute, Postoperative Central Diabetes Insipidus and Hypovolemic Shock

  2017cites this paper
• Desmopressin duration of antidiuretic action in patients with central diabetes insipidus

  2011cites this paper
• [Diabetes insipidus in pregnancy--a case report].

  2011cites this paper
• CHAPTER 10 – Posterior Pituitary

  2011cites this paper
• Clinical application of a synthetic vasopressin 1-deamino-8D-arginine vasopressin , DDAVP : effect of DDAVP on platelet function in normal subjects

  2010cites this paper
• Activation of vasopressin neurons leads to phenotype progression in a mouse model for familial neurohypophysial diabetes insipidus.

  2010cites this paper
• Effects of Lysine-Vasopressin ( LVP ) and l-Deamino-8D-Arginine-Vasopressin ( dDAVP ) upon Electrical Potential , Short-Circuit Current and Transepithelial

  2010cites this paper
• Plasma kinetics of DDAVP in man.

  2009cites this paper
• Regulation of aquaporin-2 trafficking.

  2009cites this paper
• New category of vasopressin receptor in the central nervous system. Evidence that this receptor mediates the release of a humoral factor VIII-mobilizing principle.

  2009cites this paper
• Studies on kidney function in subjects exposed to organic solvents. II. The effect of desmopressin in a concentration test and the effect of exposure to organic solvents on renal concentrating ability.

  2009cites this paper
• Laboratory differentiation of Cushing's syndrome.

  2008cites this paper
• Desmopressin for the treatment of adult nocturia

  2008cites this paper
• Impaired urine concentrating ability in Itai-itai (ouch-ouch) disease

  2006cites this paper
• THE ADMINISTRATION OF DRUGS AND VACCINES BY THE INTRANASAL ROUTE

  2006cites this paper
• Desmopressin

  2005cites this paper
• Thrombolytic therapy in acute myocardial infarction

  2005cites this paper
• Perioperative Management of Diabetes Insipidus in Children

  2004cites this paper
• Pharmacokinetics and haematological effects of desmopressin

  2004cites this paper
• Perioperative Management of Diabetes Insipidus in Children*

  2004cites this paper
• Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)

  2003cites this paper
• Evaluation of Cushing’s Syndrome

  2002cites this paper
• Oral Mucosal Drug Delivery

  2002cites this paper
• Central diabetes insipidus and heart: effect of acute arginine vasopressin deficiency and replacement treatment with desmopressin on cardiac performance

  2001cites this paper
• Osmoregulation and Desmopressin Pharmacokinetics in Enuretic Children

  1999cites this paper
• Osmoregulation and desmopressin pharmacokinetics in enuretic children.

  1999cites this paper
• The Diagnosis and Differential Diagnosis of Cushing’s Syndrome1

  1999cites this paper
• The duration of antidiuretic response of two desmopressin nasal sprays.

  1998cites this paper
• A comparative study of pharmacodynamics and bioavailability of 2 different desmopressin nasal sprays.

  1998cites this paper
• The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.

  1998cites this paper
• Impairment of bone status in patients with central diabetes insipidus.

  1998cites this paper
• The experience of dementia: a review of the literature and implications for nursing practice.

  1996cites this paper
• Diagnosis and management of diabetes insipidus during pregnancy.

  1996cites this paper
• Behavioural and Instrumental Stressors in Dementia (BISID): refocussing the assessment of caregiver need in dementia.

  1996cites this paper
• Lack of effect of desmopressin on ACTH and cortisol responses to ovine corticotropin‐releasing hormone in anorexia nervosa

  1996cites this paper
• The triple-phase response--problems of water balance after pituitary surgery.

  1995cites this paper
• Differing responses of cortisol to oCRF during endonasal and oral treatment with DDAVP

  1994cites this paper
• Pharmacokinetics of 1‐deamino‐8‐d‐arginine vasopressin after various routes of administration in healthy volunteers

  1993cites this paper
• Water‐balance hormones during long‐term follow‐up of oral dDAVP treatment in diabetes insipidus

  1993cites this paper
• Metabolic clearance of vasopressin and an analogue resistant to vasopressinase in human pregnancy.

  1993cites this paper
• [The effect of desmopressin (DDAVP) in patients complaining of nocturia].

  1993cites this paper
• Some Pharmacological Properties of Desmopressin

  1993cites this paper
• Pathophysiology of transient cranial diabetes insipidus during pregnancy

  1993cites this paper
• Pharmacokinetics of Desmopressin

  1993cites this paper
• VIGNE'ITE IN CLINICAL PATHOPHYSIOLOGY Severe Acute Peripartum Hypernatremia

  1992cites this paper
• Severe acute peripartum hypernatremia.

  1992cites this paper
• Pharmacokinetics of Peptides and Proteins: Opportunities and Challenges

  1992cites this paper
• Aggravation of subclinical diabetes insipidus during pregnancy

  1992cites this paper
• Aggravation of subclinical diabetes insipidus during pregnancy.

  1991cites this paper
• Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis.

  1991cites this paper
• The diagnosis and differential diagnosis of Cushing's syndrome

  1991cites this paper
• Continuous vasopressin replacement in diabetes insipidus.

  1990cites this paper
• Basic Pharmacology of Desmopressin

  1990cites this paper
• Changes in the metabolic clearance of vasopressin and in plasma vasopressinase throughout human pregnancy.

  1989cites this paper
• Volume homeostasis and osmoregulation in human pregnancy.

  1989cites this paper
• 8 Volume homeostasis and osmoregulation in human pregnancy

  1989cites this paper
• Clinical use of vasopressin analogues.

  1989cites this paper
• Osmoregulation of thirst and vasopressin release in pregnancy.

  1989cites this paper
• Nasal drug delivery: An in vitro characterization of transepithelial electrical properties and fluxes in the presence or absence of enhancers

  1988cites this paper
• Growth-promoting activity of desmopressin in murine leukemia cells treated in vitro.

  1988cites this paper
• Management of early postoperative diabetes insipidus with parenteral desmopressin.

  1988cites this paper
• Diabetes insipidus in pregnancy.

  1987cites this paper
• Ultralow doses of yasopressin in the management of diabetes insipidus

  1987cites this paper
• Intranasal drug delivery for systemic medications.

  1987cites this paper
• Carrier‐mediated transport of vasorpressin across the blood‐brain barrier of the mouse

  1987cites this paper
• Diabetes insipidus in pregnancy associated with abnormally high circulating vasopressinase activity.

  1987cites this paper
• Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.

  1987cites this paper
• Comparative Study of Intranasal, Subcutaneous and Intravenous Administration of Desamino-D-Arginine Vasopressin (DDAVP)

  1986cites this paper
• Biological effect and plasma concentrations of DDAVP after intranasal and peroral administration to humans.

  1986cites this paper
• Biopharmaceutical Aspects on the Intranasal Administration of Peptides

  1986cites this paper
• MANAGEMENT OF CRANIAL DIABETES INSIPIDUS WITH ORAL DESMOPRESSIN (DDAVP)

  1986cites this paper
• DDAVP and urine osmolality in refractory enuresis.

  1986cites this paper
• Pharmacokinetics of gonadotropin-releasing hormone and its analogs.

  1986cites this paper
• Delivery Systems for Peptide Drugs

  1986cites this paper
• Absorption of intragastrically administered DDAVP in conscious dogs.

  1986cites this paper
• HORMONAL AND CARDIOVASCULAR RESPONSES TO DDAVP IN MAN

  1986cites this paper
• Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children.

  1986cites this paper
• BIOPHARMACEUTICAL ASPECI'S ON THE INTRANASAL ADMINISTRATION OF PEPTIDES

  1986cites this paper
• Drugs Five Years Later: Desmopressin

  1985cites this paper
• Use of three specific radioimmunoassays in measuring neurohypophysial hormone content and plasma concentrations of vasopressin, oxytocin and DDAVP in rats after prolonged infusion of DDAVP

  1985cites this paper
• [Intranasal TRH for the stimulation of hypophyseal and thyroid reserves. Preliminary report].

  1985cites this paper
• Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.

  1985cites this paper
• Tolerability of combined treatment with verapamil and beta-blockers in angina resistant to monotherapy.

  1985cites this paper
• Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.

  1985cites this paper
• INTRANASAL THYROTROPHIN RELEASING HORMONE IS A POTENT STIMULUS FOR TSH RELEASE IN MAN (COMPARISON WITH INTRAVENOUS AND ORAL TRH)

  1985cites this paper
• Desmopressin.

  1985cites this paper
• Plasma concentrations of 1-deamino-8-D-arginine vasopressin after intragastric administration in the rat.

  1985cites this paper
• Effects of lysine-vasopressin (LVP) and 1-deamino-8-D-arginine-vasopressin (dDAVP) upon electrical potential, short-circuit current and transepithelial D.C. resistance of the frog skin.

  1984cites this paper
• Disorders of Vasopressin Function

  1984cites this paper
• A bivariate radioimmunoassay for arginine vasopressin and the synthetic antidiuretic agent 1-deamino-8-D-arginine vasopressin (desmopressin).

  1984cites this paper
• Management of Neurogenic Diabetes Insipidus with dDAVP and Other Agents

  1984cites this paper
• Impermeability of the blood‐cerebrospinal fluid barrier to 1‐deamino‐8‐D‐arginine‐vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus

  1984cites this paper
• Antidiuretic response in conscious dogs following peroral administration of arginine vasopressin and its analogues.

  1983cites this paper
• Evaluation of renal concentrating ability with DDAVP and pitressin.

  1983cites this paper
• [Autoimmune form of central diabetes insipidus with antibodies against vasopressin-producing hypothalamic cells].

  1983cites this paper